Nevo D, Ogino S, Wang M
Int J Epidemiol. 2021; 50(3):1030-1037.
PMID: 33484125
PMC: 8485684.
DOI: 10.1093/ije/dyaa278.
Jatho A, Tran B, Cambia J, Nanyingi M, Mugisha N
Ann Glob Health. 2020; 86(1):78.
PMID: 32704483
PMC: 7350938.
DOI: 10.5334/aogh.2873.
Hamada T, Nowak J, Milner Jr D, Song M, Ogino S
J Pathol. 2019; 247(5):615-628.
PMID: 30632609
PMC: 6509405.
DOI: 10.1002/path.5236.
Hamada T, Keum N, Nishihara R, Ogino S
J Gastroenterol. 2016; 52(3):265-275.
PMID: 27738762
PMC: 5325774.
DOI: 10.1007/s00535-016-1272-3.
Ogino S, Nishihara R, VanderWeele T, Wang M, Nishi A, Lochhead P
Epidemiology. 2016; 27(4):602-11.
PMID: 26928707
PMC: 4892980.
DOI: 10.1097/EDE.0000000000000471.
FAS rs2234767 and rs1800682 polymorphisms jointly contributed to risk of colorectal cancer by affecting SP1/STAT1 complex recruitment to chromatin.
Wang S, Wu S, Meng Q, Li X, Zhang J, Chen R
Sci Rep. 2016; 6:19229.
PMID: 26759270
PMC: 4725756.
DOI: 10.1038/srep19229.
Statistical methods for studying disease subtype heterogeneity.
Wang M, Spiegelman D, Kuchiba A, Lochhead P, Kim S, Chan A
Stat Med. 2015; 35(5):782-800.
PMID: 26619806
PMC: 4728021.
DOI: 10.1002/sim.6793.
Molecular pathological epidemiology gives clues to paradoxical findings.
Nishihara R, VanderWeele T, Shibuya K, Mittleman M, Wang M, Field A
Eur J Epidemiol. 2015; 30(10):1129-35.
PMID: 26445996
PMC: 4639412.
DOI: 10.1007/s10654-015-0088-4.
Proceedings of the second international molecular pathological epidemiology (MPE) meeting.
Ogino S, Campbell P, Nishihara R, Phipps A, Beck A, Sherman M
Cancer Causes Control. 2015; 26(7):959-72.
PMID: 25956270
PMC: 4466011.
DOI: 10.1007/s10552-015-0596-2.
Progress and opportunities in molecular pathological epidemiology of colorectal premalignant lesions.
Lochhead P, Chan A, Giovannucci E, Fuchs C, Wu K, Nishihara R
Am J Gastroenterol. 2014; 109(8):1205-14.
PMID: 24935274
PMC: 4125459.
DOI: 10.1038/ajg.2014.153.
Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression.
Lochhead P, Chan A, Nishihara R, Fuchs C, Beck A, Giovannucci E
Mod Pathol. 2014; 28(1):14-29.
PMID: 24925058
PMC: 4265316.
DOI: 10.1038/modpathol.2014.81.
Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability.
Brandstedt J, Wangefjord S, Nodin B, Eberhard J, Jirstrom K, Manjer J
BMC Cancer. 2014; 14:371.
PMID: 24885829
PMC: 4041054.
DOI: 10.1186/1471-2407-14-371.
Effects of common polymorphisms rs2910164 in miR-146a and rs11614913 in miR-196a2 on susceptibility to colorectal cancer: a systematic review meta-analysis.
Wan D, Gu W, Xu G, Shen C, Ding D, Shen S
Clin Transl Oncol. 2014; 16(9):792-800.
PMID: 24399071
DOI: 10.1007/s12094-013-1150-x.
Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acids.
Zaidi N, Lupien L, Kuemmerle N, Kinlaw W, Swinnen J, Smans K
Prog Lipid Res. 2013; 52(4):585-9.
PMID: 24001676
PMC: 4002264.
DOI: 10.1016/j.plipres.2013.08.005.
A prospective study of duration of smoking cessation and colorectal cancer risk by epigenetics-related tumor classification.
Nishihara R, Morikawa T, Kuchiba A, Lochhead P, Yamauchi M, Liao X
Am J Epidemiol. 2013; 178(1):84-100.
PMID: 23788674
PMC: 3698990.
DOI: 10.1093/aje/kws431.
Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with β-catenin (CTNNB1) status.
Morikawa T, Kuchiba A, Lochhead P, Nishihara R, Yamauchi M, Imamura Y
Cancer Res. 2013; 73(5):1600-10.
PMID: 23442321
PMC: 3594537.
DOI: 10.1158/0008-5472.CAN-12-2276.
The mTOR Pathway and the Role of Energy Balance Throughout Life in Colorectal Cancer Etiology and Prognosis: Unravelling Mechanisms Through a Multidimensional Molecular Epidemiologic Approach.
Weijenberg M, Hughes L, Bours M, Simons C, van Engeland M, van den Brandt P
Curr Nutr Rep. 2013; 2(1):19-26.
PMID: 23396869
PMC: 3562550.
DOI: 10.1007/s13668-012-0038-7.
Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease.
Ogino S, Lochhead P, Chan A, Nishihara R, Cho E, Wolpin B
Mod Pathol. 2013; 26(4):465-84.
PMID: 23307060
PMC: 3637979.
DOI: 10.1038/modpathol.2012.214.
Prospective study of family history and colorectal cancer risk by tumor LINE-1 methylation level.
Ogino S, Nishihara R, Lochhead P, Imamura Y, Kuchiba A, Morikawa T
J Natl Cancer Inst. 2012; 105(2):130-40.
PMID: 23175808
PMC: 3545905.
DOI: 10.1093/jnci/djs482.
Ogino et Al. Respond to "the 21st century epidemiologist".
Ogino S, Beck A, King E, Sherman M, Milner D, Giovannucci E
Am J Epidemiol. 2012; 176(8):672-4.
PMID: 22935516
PMC: 3571249.
DOI: 10.1093/aje/kws229.